iiinova — where your digital self keeps evolving

Reposted by @grahamabra.bsky.social

ASN Publications @asnpublications.bsky.social · 14/01/2026

This study in #ASNKidney360 examined depletion of the antioxidant ergothioneine in patients undergoing dialysis. They compared levels in blood from patients on peritoneal dialysis hemodialysis, and healthy controls. Read more about what they found: kidney.pub/KID1105 @grahamabra.bsky.social

021

Reposted by @grahamabra.bsky.social

Michelle Rheault, MD @rheaultm.bsky.social · 23/12/2025

New out today: Antiproteinuric Effect of Sparsentan in Patients with Genetic-Associated FSGS Enrolled in the DUPLEX Trial Genetic FSGS CAN be treated. journals.lww.com/cjasn/abstra...

21910

Reposted by @grahamabra.bsky.social

UCSF Nephrology @ucsfnephrology.bsky.social · 17/12/2025

#NephJC the editorialist wondered if our control arm represented ‘unnecessary dialysis’ and was not ‘standard of care’—sounds like many at #NephJC do not feel the same way?

241

Reposted by @grahamabra.bsky.social

UCSF Nephrology @ucsfnephrology.bsky.social · 17/12/2025

#NephJC The traditional approach is increase in native renal function and then dialysis cessation. We proposes a different paradigm: dialysis cessation to promote increase in native renal function.

152

Reposted by @grahamabra.bsky.social

UCSF Nephrology @ucsfnephrology.bsky.social · 17/12/2025

#NephJC it is important to point out that ‘1st day of recovery’ was defined retrospective. On that day, GFR may be very low (so not ‘recovered’ in the way many people use the word). See 2 figures below for illustration. Both these patients contributed to those Kaplan-Meier curves separating early.

382

Reposted by @grahamabra.bsky.social

Nephrology Journal Club @nephjc.bsky.social · 17/12/2025

T2f Dialysis-Free Days by Day 28: Conservative: 21 days Conventional: 5 days Most pronounced divergence within the first 10-12 days Clinically, this means these patients spent most of their hospital course not needing dialysis, something no earlier AKI-D trial has demonstrated so clearly. #NephJC

173

Reposted by @grahamabra.bsky.social

Nephrology Journal Club @nephjc.bsky.social · 17/12/2025

T1c #NephJC 1️⃣Conservative RRT group RRT was done only if one of the following occurred: ✅BUN >112 mg/dL ✅Potassium >6.0 mmol/L, >5.5 after meds ✅pH <7.15 or HCO3 < 12 meq/L ✅Hypoxemia or pulmonary edema ✅Symptomatic overload ✅Clinician judgment 2️⃣ Conventional RRT was 3x/wk

252

Reposted by @grahamabra.bsky.social

Nephrology Journal Club @nephjc.bsky.social · 17/12/2025

T1a Population: stable AKI-D patients with realistic renal recovery potential Exactly the “gray zone” group we debate daily whether dialysis continuation is necessary. 👀Check out the inclusion/exclusion criteria #NephJC

033

Reposted by @grahamabra.bsky.social

nephroninja.bsky.social @nephroninja.bsky.social · 17/12/2025

Hi! I'm a nephrologist and clinical researcher at UCSF. COI: I was one of the LIBERATE-D investigators at the UCSF site. I made a BlueSky account today to join this discussion. #NephJC

2101

grahamabra.bsky.social @grahamabra.bsky.social · 17/12/2025

Graham Abra Clinical nephrologist and educator COI Fan of the UCSF neph team! #NephJC

030

Reposted by @grahamabra.bsky.social

UCSF Nephrology @ucsfnephrology.bsky.social · 17/12/2025

#NephJC This is Chi Hsu, senior author and one of the two PI’s for LIBERATE-D. Thanks for choosing our paper. I am borrowing UCSF Nephrology Division’s BlueSky account.

151

Reposted by @grahamabra.bsky.social

Juan Carlos Q Vélez, MD @juancarlosqvelez.bsky.social · 09/12/2025

Excited about this @theisn.org initiative, especially under the leadership of @hswapnil.medsky.social as EIC. Nephrology needed this www.theisn.org/blog/2025/12...

theisn.org

Turning clinical experience into shared knowledge: ISN launches Kidney International Case ReportsTM - International Society of Nephrology

1196

Reposted by @grahamabra.bsky.social

Stanford Department of Medicine @stanforddeptmed.bsky.social · 08/12/2025

The Stanford African Scholars in #GlobalHealth (SASH) program is fostering innovation at a time of growing global health challenges. Through partnerships & knowledge exchange, physician-leaders from African countries gain skills & insights to improve care at home. stanford.io/4pt5IKq

031

Reposted by @grahamabra.bsky.social

Sarah Sanghavi @sarahsanghavi.bsky.social · 05/12/2025

It was really interesting researching this topic. Hope it’s useful.

152

Reposted by @grahamabra.bsky.social

Evan Zeitler @littlebiggloms.bsky.social · 03/12/2025

#NephSky as I ask every match day, what is the deal? Endocrinology and Rheumatology (what I would consider the closest comps to nephro) are following almost of their spots while we continue to...not. Do we simply have too many spots?

3102

Reposted by @grahamabra.bsky.social

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 03/12/2025

Yup Figure 1.1 in incidence rate of ESRD in the US Seems to have slipped most people’s awareness 🤷🏽‍♂️

252

Reposted by @grahamabra.bsky.social

pisces01.bsky.social @pisces01.bsky.social · 03/12/2025

EPA and DHA has an effect on arrhythmias and SCD, especially formation of reentry arrhythmias. e.g. EPA and DHA modulates sodium, calcium and potassium ion channels affecting the cardiac action potential. #NephJC

153

Reposted by @grahamabra.bsky.social

pisces01.bsky.social @pisces01.bsky.social · 03/12/2025

Indeed! We did not know what to expect, but hopeful. Having worked on this for over a decade, I was initially "stunned" by the result but then not really surprised given the multitude of potential effects of EPA and DHA on the cardiovasculature, and our HD patients deficiencies in it #NephJC

063

Reposted by @grahamabra.bsky.social

Joel Topf @kidneyboy.bsky.social · 03/12/2025

Stop complaining about pill burden in ESRD! There is no pill you are giving your dialysis patient that has data half as impressive as this study. If they are taking too many pills have them stop any of the dozen pills they are taking with ZEERO data in ESRD. #NephJC

3273

Reposted by @grahamabra.bsky.social

pisces01.bsky.social @pisces01.bsky.social · 03/12/2025

Actually, we actually found the opposite - many patients were wanting a "natural" treatment and didnt mind! Some actually left the study to buy commercial fish oil as they didnt know if they had placebo. But to be fair, some also left the study due to pill burden #NephJC

382

Reposted by @grahamabra.bsky.social

Nephrology Journal Club @nephjc.bsky.social · 03/12/2025

Up next 12/16/25 (our last #NephJC of the year) LIBERATE, A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury. jamanetwork.com/jour...

082

Reposted by @grahamabra.bsky.social

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 03/12/2025

We need a daily dose of 1600 mg EPA 800 mg DHA in an ethylester mix of fish oil Did I get that right @kidneyboy.bsky.social @pisces01.bsky.social ? The same company that made it for FISH and PISCES may come out with their formulation soon #NephJC

151

Reposted by @grahamabra.bsky.social

Brian Rifkin @brianrifkin.bsky.social · 03/12/2025

Since we don’t know the mechanism (secret sauce) hard to say. Is it the EPA/DHA quantities or the ratio or the “quality”, or something else that hasn’t been considered. This is also likely the basis of conflicting data #NephJC

media.tenor.com

a baby is making a funny face with the words this is confusing me written above it .

ALT: a baby is making a funny face with the words this is confusing me written above it .

141

Reposted by @grahamabra.bsky.social

Brian Rifkin @brianrifkin.bsky.social · 03/12/2025

Maybe not as easy as it sounds #NephJC

253

grahamabra.bsky.social @grahamabra.bsky.social · 02/12/2025

My first month of trying to prescribe fish oil at the dialysis unit has been a total failure Pharmacies arn’t filling scripts and patients can’t find OTC matches to dose prescribed in PISCES Anyone having success on the high seas?

122

Reposted by @grahamabra.bsky.social

Nephrology Journal Club @nephjc.bsky.social · 26/11/2025

👇Here are the proposals for the #TopNephrology stories in 2025 🔥 Remember, you can only vote for your favorites if you have subscribed to #NephJC newsletter 📬 Soon we'll send you the voting link. Check your email. www.nephjc.com/news/2025/11...

nephjc.com

Which were the Top Nephrology Stories of 2024? — NephJC

Time to vote for the Top Stories of 2025

063

Reposted by @grahamabra.bsky.social

Nephrology Journal Club @nephjc.bsky.social · 01/12/2025

Maybe the most shocking study from #KidneyWk. 🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊? www.nephjc.com/news/pisces-fishoil

nephjc.com

Fish Oil in Dialysis: A Big Catch or an Empty Net — NephJC

Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?

02016

Reposted by @grahamabra.bsky.social

Nephrology Journal Club @nephjc.bsky.social · 01/12/2025

Holy Mackerel! 🐟 🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴‍☠️ #NephJC Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST Check out the PISCES VA by @brianrifkin.bsky.social www.nephjc.com/news/piscesva

nephjc.com

PISCES: The Visual Abstract — NephJC

Curious how n-3 PUFAs may cut serious cardiovascular events in dialysis? 🐟 A big signal, a big dose, and a big discussion ahead — don’t miss this #NephJC! Check out the VA made by our master Brian...

01411

Reposted by @grahamabra.bsky.social

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 28/11/2025

An aldosterone synthase (CYP11B2 enzyme)–specific 18F-labeled radioligand to help lateralize in PA www.nejm.org/doi/full/10.... very cool science and technology Any comments from the Aldo experts? @anandvaidya17.bsky.social #NephSky #EndoSky

2246

grahamabra.bsky.social @grahamabra.bsky.social · 26/11/2025

Cool paper Genetics of AMKD getting deeper…

040

Reposted by @grahamabra.bsky.social

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 26/11/2025

That was quick! The US FDA approves Sibeprenlimab aka Voyxact for reducing proteinuria in IgA www.fda.gov/drugs/novel-... #NephSky #TopNephrology

2207

Reposted by @grahamabra.bsky.social

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 25/11/2025

I did not know it was this bad Look at the mortality in younger females (versus males) in CKD 5 jamanetwork.com/journals/jam... in @jamainternalmed.com from Alberta #NephSky #GenderDisparities

Figure 2. Standardized Mortality Ratio and Female to Male Mortality Rate Ratio

4168

Reposted by @grahamabra.bsky.social

Juan Carlos Q Vélez, MD @juancarlosqvelez.bsky.social · 21/11/2025

1/n Recently attended an international congress about Urinalysis in Santiago, Chile 🇨🇱. I was expecting a small meeting. I was wrong. Pleasantly surprised with the size of the meeting and the energy and interest from the participants. Let me share the highlights of my experience:

2177

Reposted by @grahamabra.bsky.social

kireports.bsky.social @kireports.bsky.social · 20/11/2025

6/ 📖 Intro ⚡ SGLT2 inhibitors, first made for glucose control, surprised us with strong renal + CV protection 💥 Their small, reversible eGFR dip (like RASi) hinted at the mechanism: more Na⁺ to the macula densa → restored tubuloglomerular feedback → ⬇️ glomerular pressure → nephroprotection. 🧬

121

Reposted by @grahamabra.bsky.social

Nephrology Journal Club @nephjc.bsky.social · 19/11/2025

Up next: It might seem a little fishy, but was a great catch 🎣 #NephJC PISCES, the use of fish oil to decrease mortality in dialysis patients. www.pubmed.ncbi.nlm....

363

Reposted by @grahamabra.bsky.social

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 19/11/2025

The latest #FreelyFiltered episode has dropped www.nephjc.com/freelyfilter... With pinch hitters Brian Rifkin and Anna Gaddy

nephjc.com

FF 85 Live! From Houston, the #KidneyWk Draft — NephJC

FF 85 Live! From Houston, the #KidneyWk Draft

293

Reposted by @grahamabra.bsky.social

Matthew Sparks @nephrosparks.bsky.social · 18/11/2025

ATTN Fellows!!! Apply to be in the 3rd annual NephMadness NIT Fellows debate at NKF SCM in New Orleans Application here form.jotform.com/252084341700...

052

Reposted by @grahamabra.bsky.social

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 13/11/2025

Interesting molecule - Troxerutin as an osmotic agent for PD academic.oup.com/ndt/advance-... in @ndt-era.bsky.social It seems it’s a flavonol from the Japanese pagoda tree en.wikipedia.org/wiki/Troxeru... #PDSky #NephSky

0103

Reposted by @grahamabra.bsky.social

Rob Blaser @robertblaser.bsky.social · 12/11/2025

I realize folks have probably heard this elsewhere, but it looks like the shutdown will likely end very soon, if not tonight then tomorrow. The good health policy news is that the telehealth flexibilities will be extended until January 30 and made retroactive back to October 1. (1)

121

grahamabra.bsky.social @grahamabra.bsky.social · 10/11/2025

Community house HD continues to be a great example of patient centered care and creative thinking

020

Reposted by @grahamabra.bsky.social

NEJM.org @nejm.org · 07/11/2025

In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: nej.md/49zWuqo @asnkidney.bsky.social | #KidneyWk

American Society of Nephrology Kidney Week 2025
Original Article | Nov. 7, 2025 | NEJM.org
Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis

Fig. 1A. A Serious Cardiovascular Events

The NEJM identity sits at the bottom.

22511